Morquio Syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
Who is this for?
Show terms as
2FDA treatments5Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Morquio Syndrome is treated with 2 medications in our database, including VIMIZIM, ELAPRASE. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by BioMarin, Takeda. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Morquio Syndrome treatment below.

Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Childhood

Begins in childhood, roughly ages 1 to 12

NORD ↗

FDA & Trial Timeline

3 events
Dec 2025Radicle GI Health RDH™: A Study Assessing the Impact of Health and Wellness Products on Gastrointestinal (GI) Health and Related Health Outcomes

Radicle Science — NA

TrialNOT YET RECRUITING
Sep 2024Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation

University of Nottingham — NA

TrialRECRUITING
Jun 2023Multidisciplinary Evaluation and a Genome-wide Analysis in a Cohort of Idiopathic Short Stature Patients

University Hospital, Montpellier — NA

TrialNOT YET RECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

2 available

VIMIZIM

elosulfase alfa· BioMarin

* Patient Copay Amount: Not Publicly Available * Maximum Annual Benefit Limit: Not Publicly Available * Core Eligibility Restrictions: Not Publicly Available * RxBIN, PCN, and Group numbers: Not Publi

ELAPRASE

idursulfase· Takeda

Detailed copay and financial assistance information is not publicly available for this medication at this time. Please consult your pharmacist or the manufacturer's official patient support program fo

No actively recruiting trials found for Morquio Syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Morquio Syndrome community →

Specialists

5 foundView all specialists →
TM
Tippi C MacKenzie, MD
San Francisco, California
Specialist

Rare Disease Specialist

PI on 2 active trials
CM
Carlos R Ferreira Lopez, M.D.
Bethesda, Maryland
Specialist

Rare Disease Specialist

PI on 2 active trials
CM
Celeste Decker, MD
CONCORD, NH
Specialist
PI on 5 active trials
MM
Michael Camilleri, MD
ROCHESTER, MN
Specialist
PI on 6 active trials
NP
Nadia Ali, Ph.D.
Specialist
PI on 2 active trials

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Morquio Syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Morquio SyndromeForum →

No community posts yet. Be the first to share your experience with Morquio Syndrome.

Start the conversation →

Latest news about Morquio Syndrome

Disease timeline:

New recruiting trial: Effect of Chronic Feeding of Inulin And Methylcellulose on Colonic Fermentation

A new clinical trial is recruiting patients for Morquio Syndrome

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Morquio Syndrome

What is Morquio Syndrome?

Morquio Syndrome is treated with 2 medications in our database, including VIMIZIM, ELAPRASE. 1 of these has manufacturer assistance programs available to help reduce out-of-pocket costs. Medications are manufactured by BioMarin, Takeda. Patients and caregivers can find copay cards, patient assistance programs, and travel grants for Morquio Syndrome treatment below.

How is Morquio Syndrome inherited?

Morquio Syndrome follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Morquio Syndrome typically begin?

Typical onset of Morquio Syndrome is childhood. Age of onset can vary across affected individuals.

Which specialists treat Morquio Syndrome?

5 specialists and care centers treating Morquio Syndrome are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.

What treatment and support options exist for Morquio Syndrome?

2 FDA-approved treatments and 1 patient support program are currently tracked on UniteRare for Morquio Syndrome. See the treatments and support programs sections for copay assistance, eligibility, and contact details.